Titre :
  • Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Auteur : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ; Davies, C ; Godwin, J ; Gray, Richard ; Clarke, M.J. ; Cutter, D ; Darby, S ; McGale, P ; Pan, Huade ; Taylor, C ; Wang, Yiwei ; Dowsett, Mitch ; Ingle, James N ; Peto, R
Informations sur la publication : Lancet, 378, 9793, (page 771-784)
Statut de publication : Publié, 2011-08
Sujet CREF : Cancérologie
Mots-clés MeSH : Antineoplastic Agents, Hormonal -- adverse effects -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology
Chemotherapy, Adjuvant
Female
Humans
Neoplasm Recurrence, Local -- prevention & control
Neoplasms, Second Primary -- chemically induced
Randomized Controlled Trials as Topic
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Selective Estrogen Receptor Modulators -- adverse effects -- therapeutic use
Tamoxifen -- adverse effects -- therapeutic use
Note : Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0140-6736 
info:doi/10.1016/S0140-6736(11)60993-8
info:pii/S0140-6736(11)60993-8
info:pmid/21802721
info:pmcid/PMC3163848